The Pharmacy Times® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.
October 22nd 2024
Multiple P13K inhibitors have showed promise in treating genetically-mutated forms of breast cancer.
FDA Approves Capivasertib With Fulvestrant for PIK3CA/AKT1/PTEN Alterations Breast Cancer
November 17th 2023Capivasertib is indicated for hormone receptor-positive, human epidermal growth factor 2-negative locally advanced or metastatic breast cancer with 1 or more PIK3CA/ALT1/PTEN-alterations.
Read More
Study Results Indicate Precision Therapies Make Up Approximately Half of FDA-Approved Oncology Drugs
October 19th 2023This finding underlines the need for methods that address multiple genomic alterations and targeted therapies effective in tumors driven by variations in suppressor genes or transcription factors.
Read More
Follow-Up Survey Indicates Cancer Centers Continue to Experience Chemotherapy Shortages
October 12th 2023Larger institutions have continued to treat patients who needed carboplatin or cisplatin; however, the survey results don’t include smaller cancer centers that may face access challenges.
Read More
Expert: Reaching Out for Healthy Women, A Data-Driven Approach to Helping Women Access Health Care
October 4th 2023The manager of patient support services at St. Luke’s Cancer Center discusses the significance of Reaching Out for Healthy Women and how female patients can receive support from this initiative.
Watch
AI and Precision Medicine Are Changing What’s Possible for Breast Cancer Treatment
October 2nd 2023Ongoing studies utilizing large-scale health databases that incorporate environmental, lifestyle, biological, and phenotypic data may provide insight that leads to better cancer prevention and treatment.
Read More